Status:
WITHDRAWN
Study of Proton Pump Inhibitors (PPI) to Prevent Strictures After Gastric Bypass Surgery
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
AstraZeneca
Conditions:
Anastomotic Stricture
Morbid Obesity
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether suppressing acid production by administration of daily proton pump inhibitors in the early post-operative period will reduce the gastrojejunal anastom...
Detailed Description
Laparoscopic Roux-en-Y gastric bypass (LYRGB) has been shown to be a safe and effective procedure for the treatment of morbid obesity. However, a common early complication of LYRGB is stricture at the...
Eligibility Criteria
Inclusion
- Any patient who satisfies the requirements of the Weill-Cornell Weight Loss Surgery program to undergo laparoscopic Roux-en-Y gastric bypass surgery as treatment for morbid obesity.
Exclusion
- Patients with a history of ulcer disease, patients taking chronic acid suppression medicine, and patients taking NSAIDS.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00361985
Start Date
January 1 2008
End Date
July 1 2011
Last Update
November 1 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Medical College of Cornell Unversity
New York, New York, United States, 10021